Biomarin Pharmaceutical Inc (BMRN) Insider Trading
- $1,316,196.75
- $342,139,664.94
- Nov. 12, 2024
- Jean Jacques Bienaime
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 14, 2018 | EVP | 9,000 | $92.15 | Sell | $829,350.00 | |
Nov. 1, 2018 | CEO | 4,000 | $92.55 | Sell | $370,200.00 | |
Oct. 3, 2018 | EVP | 1,000 | $98.98 | Sell | $98,980.00 | |
Oct. 3, 2018 | CEO | 1,500 | $99.36 | Sell | $149,040.00 | |
Sept. 27, 2018 | Director | 2,150 | $97.93 | Sell | $210,549.50 | |
Sept. 13, 2018 | EVP | 12,000 | $99.57 | Sell | $1,194,840.00 | |
Sept. 13, 2018 | Director | 3,000 | $99.24 | Sell | $297,720.00 | |
Sept. 5, 2018 | Director | 1,000 | $96.94 | Sell | $96,940.00 | |
Sept. 4, 2018 | CEO | 1,500 | $98.16 | Sell | $147,240.00 | |
Aug. 27, 2018 | Insider | 25,000 | $99.50 | Sell | $2,487,500.00 | |
Aug. 27, 2018 | Director | 2,000 | $100.12 | Sell | $200,240.00 | |
Aug. 24, 2018 | Insider | 12,500 | $99.00 | Sell | $1,237,500.00 | |
Aug. 21, 2018 | Director | 4,200 | $100.09 | Sell | $420,378.00 | |
Aug. 7, 2018 | EVP | 5,173 | $105.00 | Sell | $543,165.00 | |
Aug. 7, 2018 | SVP | 2,500 | $104.50 | Sell | $261,250.00 | |
July 23, 2018 | CEO | 1,500 | $101.69 | Sell | $152,535.00 | |
June 27, 2018 | Director | 2,150 | $93.52 | Sell | $201,068.00 | |
June 22, 2018 | SVP | 3,145 | $99.50 | Sell | $312,927.50 | |
June 22, 2018 | CFO | 10,000 | $99.00 | Sell | $990,000.00 | |
June 22, 2018 | EVP | 6,949 | $99.00 | Sell | $687,951.00 | |
June 15, 2018 | SVP | 2,021 | $94.50 | Sell | $190,984.50 | |
June 14, 2018 | Insider | 31,000 | $90.00 | Sell | $2,790,000.00 | |
June 11, 2018 | EVP | 1,436 | $90.31 | Sell | $129,685.16 | |
May 17, 2018 | CEO | 18,750 | $88.66 | Sell | $1,662,375.00 | |
May 15, 2018 | CEO | 37,500 | $88.75 | Sell | $3,328,125.00 | |
May 11, 2018 | CEO | 18,750 | $88.42 | Sell | $1,657,875.00 | |
May 10, 2018 | SVP | 2,450 | $89.50 | Sell | $219,275.00 | |
May 7, 2018 | EVP | 309 | $85.96 | Sell | $26,561.64 | |
April 24, 2018 | CEO | 20,000 | $82.43 | Sell | $1,648,600.00 | |
April 23, 2018 | CFO | 11,059 | $82.15 | Sell | $908,496.85 | |
April 20, 2018 | CEO | 10,000 | $83.65 | Sell | $836,500.00 | |
April 17, 2018 | Director | 3,750 | $85.00 | Sell | $318,750.00 | |
April 2, 2018 | EVP | 2,119 | $80.12 | Sell | $169,774.28 | |
April 2, 2018 | Insider | 10,000 | $80.12 | Sell | $801,200.00 | |
March 29, 2018 | EVP | 1,537 | $79.69 | Sell | $122,483.53 | |
March 23, 2018 | EVP | 3,350 | $81.35 | Sell | $272,522.50 | |
March 21, 2018 | EVP | 4,368 | $83.90 | Sell | $366,475.20 | |
March 16, 2018 | EVP | 3,818 | $83.88 | Sell | $320,253.84 | |
March 15, 2018 | CEO | 15,000 | $84.73 | Sell | $1,270,950.00 | |
March 9, 2018 | EVP | 2,972 | $82.39 | Sell | $244,863.08 | |
March 5, 2018 | EVP | 2,105 | $79.04 | Sell | $166,379.20 | |
Feb. 15, 2018 | CEO | 10,000 | $84.63 | Sell | $846,300.00 | |
Feb. 1, 2018 | EVP | 30,000 | $90.66 | Sell | $2,719,800.00 | |
Jan. 5, 2018 | CEO | 10,000 | $90.32 | Sell | $903,200.00 | |
Jan. 2, 2018 | Director | 3,750 | $88.84 | Sell | $333,150.00 | |
Jan. 2, 2018 | Insider | 15,000 | $89.23 | Sell | $1,338,450.00 | |
Dec. 29, 2017 | CEO | 10,000 | $89.61 | Sell | $896,100.00 | |
Dec. 29, 2017 | CEO | 20,000 | $89.75 | Sell | $1,795,000.00 | |
Dec. 14, 2017 | Director | 800 | $88.90 | Sell | $71,120.00 | |
Nov. 30, 2017 | EVP | 1,200 | $85.64 | Sell | $102,768.00 |
Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.
The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere
The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.
Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.
David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.
The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.
The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.
The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.